DNA Liquid B Early Detection Cancer Test & Reports
- Regular price
- Sale price
- Regular price
Description
Description
DNA Liquid B is an FDA-approved, advanced multi-cancer early detection test that identifies the presence of cancer signals in your body through a simple blood draw. Designed to detect multiple types of cancer, DNA Liquid B excels at catching cancer signals early, often before any symptoms arise. This early detection is critical, as many cancers remain undetected until later stages when treatment options are more limited. By using DNA Liquid B, you can take a proactive approach to your health, potentially detecting cancers at an early and more treatable stage, giving you more time and options for effective care.
- Access Early Detection: By scrutinizing cancer signals present in the blood, DNA Liquid B enables early detection, enhancing prevention efforts.
-
Improve Treatment Effectiveness: Leveraging next-generation sequencing
technology, DNA Liquid B assesses treatment effectiveness, guiding
personalized therapeutic strategies. -
Comprehensive, Proactive Monitoring: With detailed reports encompassing up
to 16 types of cancer, DNA Liquid B provides ongoing monitoring for potential
disease resurgence or recurrence, empowering proactive healthcare
management.
**Please Note: Due to shipping restrictions and regulations, we currently DO NOT offer our Liquid B Test outside the US
Couldn't load pickup availability
Take Control of Your Future
Being proactive about cancer screening is essential for catching potential issues early and staying ahead of the game. Rather than waiting for symptoms to arise, taking a proactive approach involves regular check-ups and screenings to detect any abnormalities at their earliest stages. Early detection significantly increases the chances of successful treatment and improves outcomes. By staying ahead with proactive cancer screening, individuals can empower themselves with knowledge about their health status, enabling timely interventions and potentially saving lives.
Early Detection, Improved Survival
Statistics show that early detection of cancer through advanced screening methods dramatically improves survival rates and treatment outcomes. According to the American Cancer Society, the five-year survival rate for localized colorectal cancer—meaning it’s detected early before spreading—is 91%, compared to just 14% when it is diagnosed at a distant stage. Similarly, the National Cancer Institute reports that early-stage detection of colorectal cancer significantly increases the chances of successful treatment and reduces the need for more aggressive interventions. By utilizing advanced screening techniques like DNA Liquid B, cancers can be identified at their earliest, most treatable stages, improving patient outcomes and overall quality of life.
Stay Ahead with DNA Liquid B
Take a proactive approach to cancer with DNA Liquid B cancer screening, a crucial tool in early prevention and treatment. By detecting potential cancer markers early, DNA Liquid B enables proactive intervention, helping you avoid the development of cancer undetected. With early detection, you have the best chance at survival, as it allows for timely treatment and management. Don't wait for symptoms to appear—take control of your health and stay proactive with DNA Liquid B cancer screening.
FAQs
How does DNA Liquid B work?
Cancers present in the body release DNA into the bloodstream. Although there are numerous cancer types, these DNA fragments can serve as a distinct “fingerprint” of cancer. The DNA Liquid B test screens for several of the most lethal cancers before symptoms appear, including those for which no standard screening tests exist. When a Cancer Signal is detected, the results also indicate the predicted origin of the Cancer Signal, assisting your healthcare provider in determining the appropriate next steps for diagnosis.
What makes DNA Liquid B different from other cancer detection methods?
Unlike traditional biopsy methods that are invasive and limited to specific areas, DNA Liquid B is a non-invasive blood test that can detect cancer signals throughout the body. It provides a comprehensive analysis of multiple cancer types, enables early detection, and offers ongoing monitoring, making it a versatile tool in cancer management.
How is DNA Liquid B used in cancer treatment?
DNA Liquid B provides healthcare professionals with detailed information about cancer markers in the blood. This data can guide personalized therapeutic strategies, assess the effectiveness of current treatments, and help adjust treatment plans as needed. It allows for a more tailored approach to managing cancer as a chronic condition.
How does DNA Liquid B aid in early detection of cancer?
By analyzing cancer signals in the blood, DNA Liquid B enables the early detection of cancer, often before symptoms appear or traditional imaging methods can detect it. This early detection is crucial for enhancing prevention efforts and improving overall treatment outcomes.
What types of cancer can DNA Liquid B detect and monitor?
DNA Liquid B identifies signals linked to over 50 different types of cancer, including several aggressive forms that account for about two-thirds of cancer-related deaths. As a cancer screening test, DNA Liquid B is intended to detect cancer before symptoms arise. However, it should be noted that this test does not identify signals for all cancer types, and not all cancers can be detected through a blood sample.
How is the DNA Liquid B test performed?
The DNA Liquid B test is performed through a simple blood draw. When you are ready to take the DNA Liquid B test, you can arrange your blood draw at a convenient time and place for you, either at one of our partner labs or in your home, office, or any other preferred location with the assistance of a trained technician. Please note that fasting is not required for this test.
How long does it take to receive results from DNA Liquid B?
Results from the DNA Liquid B test are typically available within 2-3 weeks after the blood sample is received at the lab. You will receive a detailed report that outlines the findings and any recommendations for further action or monitoring.
How does DNA Liquid B compare to other liquid biopsy tests?
DNA Liquid B provides an extensive screening solution by identifying signals linked to over 50 different types of cancer, including several aggressive forms. Designed to detect cancer before symptoms manifest, DNA Liquid B offers a proactive approach to early detection and ongoing monitoring. Some other liquid biopsy tests may focus on a narrower range of cancers or provide less detailed information, making DNA Liquid B a more versatile and proactive choice for cancer management.
Who can use DNA Liquid B?
The DNA Liquid B test is designed for adults at an increased risk of cancer, particularly those aged 50 and older. However, it is not advised for use in pregnant individuals, those 21 years old or younger, or anyone currently undergoing active cancer treatment.DNA Liquid B is currently available in the United States only.
Is DNA Liquid B a replacement for traditional cancer diagnostics?
While DNA Liquid B provides valuable insights and complements traditional cancer diagnostics, it is not a complete replacement. It is used in conjunction with other diagnostic tools, imaging, and clinical evaluations to provide a comprehensive picture of an individual’s cancer status.
How we’ve changed lives
“I was extremely impressed with the detailed report and was able to immediately take action and see improvements in my life. An example, my eyesight had been declining since turning 30 and my DNA report mentioned that I had a genetic expression that didn't allow me to absorb vitamin A very well. I immediately started taking a certain kind of vitamin A that was recommended by the DNA report and I no longer wear my glasses or have headaches. ”
Jacqueline S.
“The reports and amount of information were much more comprehensive than I thought they would be. Almost uncanny how it pegged my sleeping habits. The most important find was my nutritional challenges and my inability to rid myself naturally from toxins, as well as the recommendations. I could make an argument that the reports may have saved my life. ”
Mark M.
“ I've suffered from food intolerances for 30 years and have been endlessly trying to "fix my gut" problems with different diets and supplements. This report has made me aware that the symptoms I experienced are actually related to my DNA and lack of some genes. I plan to implement many of the suggestions that have been offered in this report in hopes of reducing some of those symptoms. ”
Becky R.
“Learning about my genes has really helped me devise a nutrition strategy that has increased my energy and improved my overall health and well-being. The reports were so accurate and revealing to what makes me tick. I have made amazing progress in every area of my life by following the suggested protocols in the reports. ”
William J.